These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3689055)

  • 1. Frontal lobe degeneration of non-Alzheimer type. III. Regional cerebral blood flow.
    Risberg J
    Arch Gerontol Geriatr; 1987 Sep; 6(3):225-33. PubMed ID: 3689055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral blood flow in frontal lobe dementia of non-Alzheimer type.
    Risberg J; Passant U; Warkentin S; Gustafson L
    Dementia; 1993; 4(3-4):186-7. PubMed ID: 8401790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of dementia by regional cerebral blood flow measurements using 133Xe and stationary detectors.
    Risberg J
    Acta Neurol Scand Suppl; 1996; 168():59-62. PubMed ID: 8997422
    [No Abstract]   [Full Text] [Related]  

  • 4. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.
    Brun A
    Arch Gerontol Geriatr; 1987 Sep; 6(3):193-208. PubMed ID: 3689053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synapse density related to cerebral blood flow and symptomatology in frontal lobe degeneration and Alzheimer's disease.
    Liu X; Passant U; Risberg J; Warkentin S; Brun A
    Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():64-70. PubMed ID: 10436344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia.
    Starkstein SE; Migliorelli R; Tesón A; Sabe L; Vázquez S; Turjanski M; Robinson RG; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):790-6. PubMed ID: 8021663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.
    Pagani M; Kovalev VA; Lundqvist R; Jacobsson H; Larsson SA; Thurfjell L
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1481-8. PubMed ID: 14579087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow patterns underlying the differential impairment in category vs letter fluency in Alzheimer's disease.
    Keilp JG; Gorlyn M; Alexander GE; Stern Y; Prohovnik I
    Neuropsychologia; 1999 Oct; 37(11):1251-61. PubMed ID: 10530725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test.
    Warkentin S; Passant U
    Dement Geriatr Cogn Disord; 1997; 8(2):105-9. PubMed ID: 9065323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single photon tomography in Alzheimer's disease and the dementias.
    Bonte FJ; Hom J; Tintner R; Weiner MF
    Semin Nucl Med; 1990 Oct; 20(4):342-52. PubMed ID: 2237452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis.
    Gustafson L
    Arch Gerontol Geriatr; 1987 Sep; 6(3):209-23. PubMed ID: 3689054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine reduces frontal cortex perfusion.
    Honer WG; Prohovnik I; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1988 Oct; 8(5):635-41. PubMed ID: 3417793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical perfusion and gray matter weight in frontal lobe dementia.
    Alexander GE; Prohovnik I; Sackeim HA; Stern Y; Mayeux R
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):188-96. PubMed ID: 7626962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow measurements in the clinical evaluation of demented patients.
    Risberg J; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(2):92-7. PubMed ID: 9065321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
    Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I; Arnold SE; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofrontality and negative symptoms in patients with dementia of Alzheimer type.
    Galynker II; Dutta E; Vilkas N; Ongseng F; Finestone H; Gallagher R; Serseni D; Rosenthal RN
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jan; 13(1):53-9. PubMed ID: 10645737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.
    Brun A; Passant U
    Acta Neurol Scand Suppl; 1996; 168():28-30. PubMed ID: 8997416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients.
    Hanyu H; Kume K; Sato T; Hirao K; Kanetaka H; Sakurai H; Iwamoto T
    J Neurol Sci; 2012 Dec; 323(1-2):71-6. PubMed ID: 22967747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.